96 related articles for article (PubMed ID: 26417297)
1. Identification of circulating miRNAs profiles that distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Gayosso-Gómez LV; Zárraga-Granados G; Paredes-Garcia P; Falfán-Valencia R; Vazquez-Manríquez ME; Martinez-Barrera LM; Castillo-Gonzalez P; Rumbo-Nava U; Guevara-Gutierrez R; Rivera-Bravo B; Ramirez-Venegas A; Sansores R; Negrete-Garcia MC; Ortiz-Quintero B
EXCLI J; 2014; 13():740-50. PubMed ID: 26417297
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
Bruno R; Alì G; Fontanini G
J Thorac Dis; 2018 Jan; 10(Suppl 2):S342-S352. PubMed ID: 29507804
[TBL] [Abstract][Full Text] [Related]
4. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
[TBL] [Abstract][Full Text] [Related]
5. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
7. Genomics of Tumor Origin and Characteristics for Adenocarcinoma and Malignant Pleural Mesothelioma: A Case Report.
Usuda K; Niida Y; Ishikawa M; Iwai S; Yamagata A; Iijima Y; Motono N; Yamada S; Uramoto H
Front Oncol; 2022; 12():858094. PubMed ID: 35664766
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
9. Melodic maestros: Unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma.
Abd-Elmawla MA; Abdel Mageed SS; Al-Noshokaty TM; Elballal MS; Abulsoud AI; Elshaer SS; El-Husseiny AA; Fathi D; Midan HM; Rizk NI; Elrebehy MA; Sayed GA; Tabaa MME; Salman A; Mohammed OA; Ashraf A; Khidr EG; Khaled R; El-Dakroury WA; Helal GK; Moustafa YM; Doghish AS
Pathol Res Pract; 2023 Oct; 250():154817. PubMed ID: 37713736
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Truini A; Coco S; Nadal E; Genova C; Mora M; Dal Bello MG; Vanni I; Alama A; Rijavec E; Biello F; Barletta G; Merlo DF; Valentino A; Ferro P; Ravetti GL; Stigliani S; Vigani A; Fedeli F; Beer DG; Roncella S; Grossi F
Oncotarget; 2017 Sep; 8(40):68627-68640. PubMed ID: 28978143
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
[TBL] [Abstract][Full Text] [Related]
12. Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study.
Casalone E; Birolo G; Pardini B; Allione A; Russo A; Catalano C; Mencoboni M; Ferrante D; Magnani C; Sculco M; Dianzani I; Grosso F; Mirabelli D; Filiberti RA; Rena O; Sacerdote C; Rodriguez-Barranco M; Smith-Byrne K; Panico S; Agnoli C; Johnson T; Kaaks R; Tumino R; Huerta JM; Riboli E; Heath AK; Trobajo-Sanmartín C; Schulze MB; Saieva C; Amiano P; Agudo A; Weiderpass E; Vineis P; Matullo G
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612122
[TBL] [Abstract][Full Text] [Related]
13. Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker.
Hosako M; Muto T; Nakamura Y; Tsuta K; Tochigi N; Tsuda H; Asamura H; Tomonaga T; Kawai A; Kondo T
J Proteomics; 2012 Jan; 75(3):833-44. PubMed ID: 22051404
[TBL] [Abstract][Full Text] [Related]
14. Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation.
Ferrari L; Carugno M; Mensi C; Pesatori AC
Front Oncol; 2020; 10():445. PubMed ID: 32318342
[TBL] [Abstract][Full Text] [Related]
15. Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma.
Torricelli F; Lococo F; Di Stefano TS; Lorenzini E; Piana S; Valli R; Rena O; Veronesi G; Billè A; Ciarrocchi A
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32872534
[TBL] [Abstract][Full Text] [Related]
16. Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma.
Lv S; Xue J; Wu C; Wang L; Wu J; Xu S; Liang X; Lou J
J Cancer; 2017; 8(1):48-56. PubMed ID: 28123597
[No Abstract] [Full Text] [Related]
17. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment.
Grigoriu BD; Scherpereel A; Devos P; Chahine B; Letourneux M; Lebailly P; Grégoire M; Porte H; Copin MC; Lassalle P
Clin Cancer Res; 2007 May; 13(10):2928-35. PubMed ID: 17504993
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.
Martarelli D; Catalano A; Procopio A; Orecchia S; Libener R; Santoni G
BMC Cancer; 2006 May; 6():130. PubMed ID: 16704740
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma.
Yamada S; Tabata C; Tabata R; Fukuoka K; Nakano T
Clin Chem Lab Med; 2011 Oct; 49(10):1721-6. PubMed ID: 21692685
[TBL] [Abstract][Full Text] [Related]
20. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma.
Bueno R; Reblando J; Glickman J; Jaklitsch MT; Lukanich JM; Sugarbaker DJ
Ann Thorac Surg; 2004 Nov; 78(5):1774-6. PubMed ID: 15511473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
